APA (7th ed.) Citation

Prondzynski, M., & Müller, O. J. (2017). Evaluation of MYBPC3 trans-splicing and gene replacement as therapeutic options in human iPSC-Derived cardiomyocytes. Molecular therapy. Nucleic Acids, 7, . https://doi.org/10.1016/j.omtn.2017.05.008

Chicago Style (17th ed.) Citation

Prondzynski, Maksymilian, and Oliver J. Müller. "Evaluation of MYBPC3 Trans-splicing and Gene Replacement as Therapeutic Options in Human IPSC-Derived Cardiomyocytes." Molecular Therapy. Nucleic Acids 7 (2017). https://doi.org/10.1016/j.omtn.2017.05.008.

MLA (9th ed.) Citation

Prondzynski, Maksymilian, and Oliver J. Müller. "Evaluation of MYBPC3 Trans-splicing and Gene Replacement as Therapeutic Options in Human IPSC-Derived Cardiomyocytes." Molecular Therapy. Nucleic Acids, vol. 7, 2017, https://doi.org/10.1016/j.omtn.2017.05.008.